Stock Detail
DARA BIOSCIENCES INC
Biotechnology
DARA @ Yahoo Finance | DARA Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $1.48 | $1.65 | $-0.10 | -6.34% | 0.00 | $1.58 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $1.58 | $1.41 | 35,292 | 7.65M | 69,306 | -1.59 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 1.75 | 1.61 | 1.51 | 1.37 | 1.27 |
Stock Profile
DARA BioSciences, Inc., a development-stage pharmaceutical company, develops a portfolio of therapeutic candidates for neuropathic pain, dermatological disorders, and metabolic diseases, including type 2 diabetes. It is developing a Phase 2a clinical trial candidate, KRN5500, for the treatment of neuropathic pain. The company also has various preclinical therapeutic candidates, including DB160, DB959, DB900, and DB200 for the treatment of metabolic diseases, dermatology, chronic neuropathic pain, Parkinson's disease, cardiovascular, and central nervous system disorders. The company is based in Raleigh, North Carolina.